Home
Search
Study Topics
Glossary
|
|
|
|
|
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date † | June 4, 2008 | ||||
Last Updated Date | August 22, 2008 | ||||
Start Date † | June 2008 | ||||
Current Primary Outcome Measures † | |||||
Original Primary Outcome Measures † | |||||
Change History | Complete list of historical versions of study NCT00691925 on ClinicalTrials.gov Archive Site | ||||
Current Secondary Outcome Measures † | |||||
Original Secondary Outcome Measures † | |||||
Descriptive Information | |||||
Brief Title † | Mitigating Pain Following Refractive Surgery | ||||
Official Title † | Contact Lens for Mitigating Pain Following Refractive Procedure | ||||
Brief Summary | Using Contact lens following refractive procedure to reduce pain. |
||||
Detailed Description | Patients at day 1 following the procedure will be treated with a contact lens and assessed for pain at 1,2,4 hours and 1,3,5 days. prospective comparative study |
||||
Study Phase | |||||
Study Type † | Observational | ||||
Study Design † | Cohort, Prospective | ||||
Condition † | Pain | ||||
Intervention † | |||||
Study Arms / Comparison Groups | bilateral post refractive surgery subject | ||||
Publications * | |||||
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status † | Recruiting | ||||
Estimated Enrollment † | 10 | ||||
Estimated Completion Date | August 2008 | ||||
Estimated Primary Completion Date | July 2008 (final data collection date for primary outcome measure) | ||||
Eligibility Criteria † | Inclusion Criteria:
Exclusion Criteria:
|
||||
Gender | Both | ||||
Ages | 18 Years to 60 Years | ||||
Accepts Healthy Volunteers | No | ||||
Contacts †† |
|
||||
Location Countries † | Israel | ||||
Expanded Access Status | |||||
Administrative Information | |||||
NCT ID † | NCT00691925 | ||||
Responsible Party | Osnat Ehrman, FORSIGHT | ||||
Secondary IDs †† | |||||
Study Sponsor † | FORSIGHT Vision3 | ||||
Collaborators †† | |||||
Investigators † |
|
||||
Information Provided By | FORSIGHT Vision3 | ||||
Verification Date | August 2008 | ||||
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |